Barinthus Biotherapeutics

Source: Wikipedia, the free encyclopedia.
(Redirected from
Vaccitech
)

Barinthus Biotherapeutics plc
Company typePublic
Nasdaq: BRNS
Industry
Founded2016; 8 years ago (2016)
Founder
Headquarters
Oxford Science Park, Oxford
,
United Kingdom
Websitebarinthusbio.com

Barinthus Biotherapeutics plc (formerly Vaccitech plc) is a

HPV and prostate cancer.[1][2]
Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.

Technology

The company's platforms include

tumours,[3]
as well as two SNAP synthetic platforms, SNAP-TI (SNAP-Tolerance Immunotherapy) and SNAP-CI (SNAP-Cancer Immunotherapy), previously referred to collectively as SNAPvaxTM.

History

The company was founded in 2016 as a

Sarah Gilbert and Adrian V. S. Hill at The Jenner Institute, University of Oxford.[4][5][6]

Vaccitech has been financed and supported by

Oxford Sciences Innovation (OSI).[7][8][9]

In early 2020, Vaccitech and the University of Oxford co-invented a vaccine for COVID-19 using the ChAdOx platform.[citation needed]

COVID-19 vaccine

In July 2020, it was reported that people in Brazil, South Africa and the US had been recruited to populate the vaccine trials.[10]

In July 2020, Vaccitech scientists reported in

prophylactic paracetamol
to minimize their adverse reactions.

Listing on NASDAQ

Vaccitech held an initial public offering of shares in 2021, listing on NASDAQ on 30 April 2021.[11]

References

  1. Twitter Edit this at Wikidata
  2. ^ Anon (2016). "Vaccitech Limited". companieshouse.gov.uk. London: Companies House.
  3. ^ Anon (2019). "Vaccitech - Creating ways to treat and prevent disease". vaccitech.co.uk. Vaccitech Limited.
  4. ^ Anon (2019). "Vaccitech Ltd". bloomberg.com. Bloomberg News.
  5. ^ Anon (2016). "Universal flu vaccine under development by Oxford spinout Vaccitech". ox.ac.uk. University of Oxford.
  6. ^ Anon (2019). "Vaccitech secures £20m Series A with GV, OSI and Sequoia China". innovation.ox.ac.uk. Oxford University Innovation.
  7. ^ Anon (2019). "About Vaccitech". vaccitech.co.uk. Vaccitech Limited.
  8. ^ "Inside the Chinese companies developing a Covid-19 vaccine". The Week. 3 September 2020.
  9. ^ Anon (2021). "M&G leads $168 million Vaccitech financing". mandgplc.com. M&G plc.
  10. ^ Boseley, Sarah (1 July 2020). "Oxford offers best hope for Covid-19 vaccine this year, MPs told". Guardian News & Media Limited.
  11. ^ "Vaccitech prices shares at IPO". Reuters. 30 April 2021.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Barinthus_Biotherapeutics&oldid=1215053843"